- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.94 Å
- Oligo State
- monomer
- Ligands
- 1 x AWJ: (2R)-2-[5-(6-amino-5-{(1R)-1-[2-(1,3-dihydro-2H-1,2,3-triazol-2-yl)-5-fluorophenyl]ethoxy}pyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]propane-1,2-diol(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shiba-Ishii, A. et al., Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer. Nat Cancer (2022)
- Release Date
- 2022-06-29
- Peptides
- ALK tyrosine kinase receptor: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A